Tradestie Institutional Equity Comparison Engine

AAM vs GRDN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GRDN Overall Edge

GRDN Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Guardian Pharmacy Services, Inc. (GRDN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AAM trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus GRDN at 31.3x Forward P/E and 6.5% operating margin (-1.7% YoY). In options structure, AAM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GRDN sits in SURGE (7th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GRDN
AAM N/M vs GRDN 31.3x Fwd P/E
Growth & Margin Winner GRDN
Op Margin 0.0% vs 6.5% ยท YoY +0.0% vs -1.7%
Momentum & Technical Winner GRDN
1Y +5.3% vs +70.4% ยท 52W Pos 70% vs 84%
Options & Structure Winner GRDN
UNCLASSIFIED (N/A IV) vs SURGE (7th %ile IV)
AAM NYSE
AA Mission Acquisition Corp.
Blank Checks
$10.66
+0.19% 1D
Market Cap $467.9M
1M Return -0.09%
1Y Return +5.29%
Forward P/E N/M
Unified AI Score
59.9 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 50.0 Mom 58.9
GRDN NYSE
Guardian Pharmacy Services, Inc.
Retail-Drug Stores And Proprietary Stores
$46.94
+0.58% 1D
Market Cap $3.0B
1M Return +18.57%
1Y Return +70.38%
Forward P/E 31.3x
Unified AI Score
35.9 / 100 SELL
Tech 8.0 Fund 35.0 Flow 56.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AAM +5.29% GRDN +70.38% Spread: +16.55 pp (GRDN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AAM TTM Op. Margin: 0.0% GRDN TTM Op. Margin: 6.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AAM vs GRDN. Trailing 12-month operating profitability (AAM 0.0% vs GRDN 6.5%) and valuation multiples (AAM N/M vs GRDN 31.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AAM (4) vs GRDN (6)
Institutional Metric AAM GRDN Criterion Row Winner
Market Capitalization Scale $467.9M $3.0B Larger Scale GRDN
Trailing P/E Ratio Valuation N/M 39.9x Lower Multiple GRDN
Forward P/E Ratio Valuation N/M 31.3x Lower Multiple GRDN
Revenue Growth (YoY) Growth +0.0% -1.7% Higher Growth AAM
Operating Margin (TTM) Profitability 0.0% 6.5% Higher Margin GRDN
Net Profit Margin Profitability 0.0% 5.1% Higher Margin GRDN
Return on Equity (ROE) Capital Efficiency 411.0% 32.0% Higher ROE AAM
52-Week Range Position Momentum 70% ($10โ€“$11) 84% ($26โ€“$51) Stronger Trend GRDN
Beta / 30D Volatility Risk Regime 0.01ฮฒ ยท 3% Vol 0.51ฮฒ ยท 56% Vol Lower Realized Risk AAM
Unified Institutional Score Composite Signal 59.9 / 100 (HOLD) 35.9 / 100 (SELL) Higher Composite AAM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AAM vs GRDN Buy Guide
AAM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AAM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GRDN SURGE
7d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live GRDN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AAM nor GRDN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.